ArticleBMC biotechnology2010

Human TGFalpha-derived peptide TGFalphaL3 fused with superantigen for immunotherapy of EGFR-expressing tumours.

Quanbin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.